Respiratorius
  • Home
  • About us
    • About us
    • History
    • Board of Directors and CEO
  • R and D
    • R and D
    • Scientific Publications
  • Investors
    • Investerare (SV)
    • Företrädesemission 2020
    • Investors
    • Press releases
    • Financial Reports
  • News
  • Contact
  • Sök
  • Menu

K Drott, M.D/Phd, Associate professor: VAL001 – Clinical Results & Medical Perspectives

24 januari 2019/0 Kommentarer/i News /av Malin Bergholm
Läs mer
https://www.respiratorius.com/wp-content/uploads/2019/09/KD.jpg 1039 1043 Malin Bergholm https://www.respiratorius.com/wp-content/uploads/2019/09/Respiratorius_logo-300x57.png Malin Bergholm2019-01-24 18:16:352019-10-08 11:33:27K Drott, M.D/Phd, Associate professor: VAL001 - Clinical Results & Medical Perspectives

A. Mansson, Non-Executive Director, Respiratorius: VAL001 – Business Opportunity Summary

1 januari 2019/0 Kommentarer/i News /av Malin Bergholm
Läs mer
https://www.respiratorius.com/wp-content/uploads/2019/09/AM.jpg 1039 1041 Malin Bergholm https://www.respiratorius.com/wp-content/uploads/2019/09/Respiratorius_logo-300x57.png Malin Bergholm2019-01-01 13:39:032019-09-20 14:46:32A. Mansson, Non-Executive Director, Respiratorius: VAL001 – Business Opportunity Summary

ARCHIVE

  • Respiratorius – Bolagspresentation på BioStock Live, 9 mars 2021
  • Respiratorius – Bolagspresentation på BioStock Live, 4 juni 2020
  • Respiratorius – Småbolagsdagen Stockholm den 10 juni 2020
  • BioStock VD-intervju, Respiratorius 2 juni, 2020 (Swedish)
  • Respiratorius: CEO Johan Drott presents at Growth Day 2020 (in Swedish)
  • Johan Drott, CEO presenterar på Life Science Day 2019 (Swedish)
  • Johan Drott CEO, presenterar på Redeye Investor Forum (Swedish)
  • Luftrörsvidgande effekt visad in vivo för nya substansen RES030-085 inom RESP9000
  • K Drott, M.D/Phd, Associate professor: VAL001 – Clinical Results & Medical Perspectives
  • A. Mansson, Non-Executive Director, Respiratorius: VAL001 – Business Opportunity Summary
  • Johan Drott, CEO – BioStock Life Science Summit 2018
  • Johan Drott, CEO – Stora Aktiedagen Göteborg – Respiratorius. (Swedish)

Senaste inläggen

  • Respiratorius – Bolagspresentation på BioStock Live, 9 mars 2021
  • Respiratorius – Bolagspresentation på BioStock Live, 4 juni 2020
  • Respiratorius – Småbolagsdagen Stockholm den 10 juni 2020
  • BioStock VD-intervju, Respiratorius 2 juni, 2020 (Swedish)
  • Respiratorius: CEO Johan Drott presents at Growth Day 2020 (in Swedish)

Senaste kommentarer

    Arkiv

    • mars 2021
    • juni 2020
    • november 2019
    • september 2019
    • juni 2019
    • januari 2019
    • november 2018
    • november 2017

    Kategorier

    • (SV) Pressmeddelanden
    • News

    In Short

    Respiratorius AB (publ) develops drug candidates with the goal of launching drugs to treat common diseases such as cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. The project portfolio also includes a project for improving the diagnosis of certain cardiovascular diseases using PET imaging.

    CONTACT

    Respiratorius AB
    Medicon Village

    Scheelevägen 2, 223 81 Lund, Sweden

    info@respiratorius.com
    +46 70 922 41 40

    PAGES

    • Home
    • About us
    • R and D
    • Investors
    • Press releases
    • News
    • Contact
    Scroll to top